ospemifene (Senshio®) accepted for use within NHSScotland
Scottish Medicines Consortium - SMC
Scottish Medicines Consortium
09 September 2019
The SMC has accepted ospemifene for treatment of moderate to severe symptomatic vulvar and vaginal atrophy (VVA) in post-menopausal women who are not candidates for local vaginal oestrogen therapy.